Central Serous Chorioretinopathy (CSC) Withdrawn Phase Trials for Bevacizumab (DB00112)

Also known as: Central Serous Chorioretinopathy / Central Serous Retinopathy (CSR) / Central Serous Retinopathy / Serous macular detachment

IndicationStatusPhase
DBCOND0050251 (Central Serous Chorioretinopathy (CSC))WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01256580Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMDTreatment